ON MAKING AMMENDMENTS AND SUPPLEMENTS TO THE CRIMINAL CODE OF THE Article 1. In Article 266(5) of the Criminal Code of the Republic of Armenia of 18 April 2003 (hereinafter referred to as “the Code”) and in the Annex thereto, the words “with the Annex” and “Annex” shall be replaced by “with Annex No 1” and “Annex No 1” respectively. (1) part 2(2) and part 3(2) shall be repealed; (2) parts 2.1 and 2.2 shall be added which read as follows: “2.1. Illegal preparation, processing, acquisition, storage, transportation, delivery of drastic substances, not considered as narcotic drugs or psychotropic substances, for the purpose of sales or the illegal sales thereof on a large scale — shall be punished by imprisonment for a term of maximum four years. (1) by a group of persons acting in a conspiracy; shall be punished by imprisonment for a term of four to five years.”; (3) part 5 shall be replaced by the following: “5. To define the list of toxic substances in this Code in accordance with Annex No 2 attached to (4) part 6 shall be added which reads as follows: “6. To define the large scale of drastic substances in this Code in accordance with Annex No 3 Article 3. In accordance with Annex No 1 and Annex No 2, the Code shall be supplemented with Annexes No 2 and No 3 which read as follows: 1. 3,4-methylene dioxyphenyl-2-propanone 7. Hyoscyamine camphorate (L-tropyltropat (camphorate)) 8. Hyoscyamine sulphate (L-tropyltropat (sulphate)) 9. Glyfluor (1,3-difluoropropanol-2 (1) 70 - 75%, 1-fluoro- 3- chloropropanol -2 (2) 10-20%) 12. Carbachol (N-(beta-carbamoyloxyethyl)-trimethylammonium chloride 15. Arsenious anhydride and its derivatives, including its pharmaceutical forms in different 16. Arsenic anhydride and its derivatives, including its pharmaceutical forms in different dosages 17. Novarsenol (5-(3-amino-4-hydroxyphenylarseno)-2-hydroxy-aniline-methyl-sulfoxylat) 19. Promeran (3-chlorhydrargyrum-2-metoxypropyl urea pura) and its pharmaceutical forms with 24. Cyanhydric acid and cyanides of metals 26. Strychnine nitrate and its pharmaceutical forms with different dosages 27. Synthetic, technical and potable ethyl alcohol not suitable for alcoholic products 28. Liquid that contains sodium chloride, natrium uranyl, 4-chlorobenzaldehyde 32. Tetraethyllead and its mixtures with other substances (ethyl fluid, etc) with the exception of 34. White phosphorus (yellow phosphorus) 3. 1-testosterone (17beta-hydroxy-5alpha- 8. Barbital (5,5-diethylbarbituric acid) 10. Benactyzine (amizil) (benzoic acid hydrochloride 14. Boldeone (androsta-1,4-diene-3,17-dione) 15. Bromizoval (N-(aminocarbonyl)-2-bromo-3- 2-bromo-4-(ortho-chlorophenyl)-9-methyl-6H- thieno[3,2- f]-s-triazolo[4,3-a][1,4]diazepine 18. Hexobarbital (5-(1-cyclohexene-1-il)-1,5- dimethyl-2,4,6 (1H,3H,5H)-Pyrimidinetrione } 20. Danazol (17alpha-pregna-2,4-dien-20-yno[2,3-d]- 21. Dehydrochlormethyltestosterone (4-chloro- 17beta-hydroxy-17alpha-methyl-androst-1,4-dien- 22. Desoxymethyltestosterone (17alpha-methyl- methylphenyl)imidazo[1,2-a]pyridine-3-acetamid) 6-(5-chloro-2-pyridyl)-6,7-dihydro-7-oxy-5Н- pyrrolo[3,4-b]pyrazine acid-5-ester-4-methyl-1- 7-chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4- 33. Mesterolone (1alpha-methylandrostan-odone) 34. Metadienone (methandrostenolone) (17beta- hydroxy-17alpha-methylandrost-1,4-dien-3-one) (2alpha, 17alpha-dimethyl- 5alpha-androstane-3- (17beta-hydroxy-17alpha-methyl-5alpha-androst- 39. Methyldienolone (17beta-hydroxy-17alpha- (17beta-hydroxy-17alpha-methyl-estra-4,9,11- 45. Midazolam (8-chloro-6-(2ortho-fluorophenyl)-1- methyl-4H-imidazo-[1,5-a][1,4]benzodiazepine

Source: http://www.translation-centre.am/pdf/Translat/HH_orenk/Crim_Code_HO_116_N/Criminal_Code_HO_116_N_en.pdf


Nome principio attivo: LEVODROPROPIZINA SOP, medicinale non soggetto a prescrizione medica, per le formulazioni in sciroppo; RR, farmaco soggetto a prescrizione medica, con ricetta ripetibile, per le gocce. Farmaco di classe A31, a totale carico del Servizio Sanitario Nazionale con nota 31 (Classe A: limitatamente all’indicazione: “Tosse nella tubercolosi polmonare attiva e nelle neop

Copyright © 2008-2018 All About Drugs